BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 612553)

  • 21. [Clinico-therapeutic aspects of Hodgkin's disease in childhood].
    Madon E; Baroncelli PG; Sacerdote A; Roberi PL; Cordero di Montezemolo L
    Minerva Pediatr; 1974 May; 26(17):898-906. PubMed ID: 4456215
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum copper in Hodgkin's disease: its relation to the anatomopathological variety, status and general signs].
    Aragón de la Cruz G; Otero Luna J; Criado Ortíz M; Polo Tolosana E
    Rev Clin Esp; 1975 Aug; 138(3):225-30. PubMed ID: 1178970
    [No Abstract]   [Full Text] [Related]  

  • 23. [Present-day treatment of Hodgkin's disease].
    Debray JM
    Therapie; 1977; 32(3):249-58. PubMed ID: 929496
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
    Sutcliffe SB; Economopoulos T; Wrigley PF; Stansfeld AG; Malpas JS
    Clin Oncol; 1980 Dec; 6(4):329-36. PubMed ID: 6161731
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
    Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
    Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 27. [DTIC--one component of ABVD combination therapy in Hodgkin's disease (author's transl)].
    Lutz D; Waldner R; Höcker P; Baumgartner G
    Wien Klin Wochenschr; 1978 Dec; 90(24):876-7. PubMed ID: 741755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gonadal hypotrophy and acute leukemia after chemotherapy for Hodgkin's disease. Report of a case (author's transl)].
    Lebreton C; Grange MJ; Tchernia G; Schweisguth O
    Arch Fr Pediatr; 1981 Nov; 38(9):697-9. PubMed ID: 6949500
    [No Abstract]   [Full Text] [Related]  

  • 29. The therapy of Hodgkin's disease in Nigeria: a five year study.
    Oluboyede OA; Esan GJ
    Afr J Med Med Sci; 1976 Sep; 5(3):201-7. PubMed ID: 829730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current status of chemotherapy for Hodgkin's disease].
    Löffler H; Gassmann W; Schmitz N; Pralle H
    Med Welt; 1981 Jun; 32(25):1010-6. PubMed ID: 7278578
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
    Fiacchini M; Lauria F; Mazza P; Tura S
    Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
    [No Abstract]   [Full Text] [Related]  

  • 32. The treatment of advanced Hodgkin's disease at Memorial Hospital.
    Straus DJ; Young CW; Lee BJ; Koziner B; Clarkson BD; Nisce LZ
    Clin Bull; 1980; 10(4):138-43. PubMed ID: 7214703
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of the bone marrow granulocyte reserve in patients with Hodgkin's disease during antiblastic polychemo- and radiation therapy].
    Santagati G; Nicolini E; Zibetti G; Paladini G
    Minerva Med; 1978 May; 69(25):1739-43. PubMed ID: 662176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
    Babini L; Sciascia R; Baccarani M; Emiliani E; Fiacchini M; Franchini A; Lauria F; Tura S
    Radiol Med; 1978 Feb; 64(2):113-8. PubMed ID: 684251
    [No Abstract]   [Full Text] [Related]  

  • 35. [Life expectancy in Hodgkin's disease].
    Bernadou A; Bousser J
    Rev Prat; 1974 Oct; 24(45):3999-4002. PubMed ID: 4445769
    [No Abstract]   [Full Text] [Related]  

  • 36. The response rate at chemotherapy in advanced Hodgkin's disease reflected by peripheral lymphocyte count.
    Krizan Z; Korec S; Bohunický L
    Neoplasma; 1978; 25(6):737-9. PubMed ID: 752119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary treatment of Hodgkin's disease with sequential radiation therapy and multidrug chemotherapy without initial laparotomy--splenectomy.
    Lacher MJ
    Prog Clin Cancer; 1982; 8():283-97. PubMed ID: 7156405
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of betamethasone in polychemotherapy of lymphoproliferative diseases].
    Cellerino R; Ambrosetti A; Tummarello D; Perini A; Piga A; Celebrano M
    Minerva Med; 1980 Sep; 71(32):2293-7. PubMed ID: 6933321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hodgkin's disease and hematosarcomas. Treatment trial by 2 methylhydrazines].
    Mathe G; Schneider M; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
    Concours Med; 1965 Jul; 87(27):4555-62. PubMed ID: 5841618
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination chemotherapy in Hodgkin's disease.
    Nordentoft AM; Jensen KB
    Dan Med Bull; 1973 Mar; 20(2):52-60. PubMed ID: 4688460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.